Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-120339
Filing Date
2025-05-15
Accepted
2025-05-15 08:24:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d947148d424b3.htm 424B3 37581
2 GRAPHIC g947148dsp01.jpg GRAPHIC 5550
  Complete submission text file 0001193125-25-120339.txt   46544
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 25948895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)